using ai to predict patient response to car-t cell therapy: analysis of the juliet trial
Published 1 year ago • 471 plays • Length 3:27Download video MP4
Download video MP3
Similar videos
-
1:57
using ai to predict the outcomes of patients with r/r dlbcl treated with tisagenlecleucel
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
2:44
do biomarkers exist for predicting response to car t-cell therapy?
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
0:59
identifying molecular markers for the prediction of icaht in patients receiving car t-cell therapy
-
3:39
applications of ai in hemonc: improving diagnosis & predicting outcomes and response to therapy
-
1:34
cctx-001: a novel car-t therapy for aml
-
1:52
implementing ai in hematology and the challenges this will overcome
-
2:12
barriers to the implementation and standardization of ai in the clinic
-
2:41
cell avidity as a predictor of t-cell efficacy
-
1:02
the use of car-t cell products in a real-world setting
-
1:18
the role of social media in the development of car-t therapy
-
1:39
the role of myeloid cells in car-t cell therapy
-
3:36
the future of cancer medicine and the potential for personalized precision medicine using ai tools
-
0:35
the importance of patient monitoring post-car-t treatment
-
2:10
managing hematologic toxicity associated with car-t therapy & insights into the car-hematotox score
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
7:25
ai in hematology: advances, challenges, and future applications